Evidence map›Paper›PMID 36222259›Full record

ArticleBritish journal of haematology2023

Multicentric standardization of minimal/measurable residual disease in B-cell precursor acute lymphoblastic leukaemia using next-generation flow cytometry in a low/middle-level income country.

Maura R V Ikoma-Colturato, Camila M Bertolucci, Joana E Conti-Spilari, Elen Oliveira, Anderson J Simioni, Lorena L Figueredo-Pontes, Felipe M Furtado, Ana P Alegretti, Ana P Azambuja, Fabiola Gevert and 15 more

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 16 institutions in 1 country.

Maura R V Ikoma-ColturatoHospital Amaral Carvalho, São Paulo, Brazil.ORCID 0000-0002-1473-9696
Camila M BertolucciHospital Amaral Carvalho, São Paulo, Brazil.ORCID 0000-0002-0344-5684
Joana E Conti-SpilariHospital Amaral Carvalho, São Paulo, Brazil.ORCID 0000-0002-9435-2845
Elen OliveiraInstituto de Pediatria e Puericultura Martagão Gesteira, UFRJ, Rio de Janeiro, Brazil.ORCID 0000-0001-9673-4145
Anderson J SimioniHospital Amaral Carvalho, São Paulo, Brazil.
Lorena L Figueredo-PontesDivision of Hematology, Department of Medical Images, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Felipe M FurtadoSabin Medicina Diagnóstica, Brasília, Brazil.
Ana P AlegrettiHospital de Clínicas de Porto Alegre, Rio Grande do Sul, Brazil.
Ana P AzambujaHospital Nossa Senhora das Graças, Curitiba, Brazil.ORCID 0000-0001-9884-4735
Fabiola GevertHospital Pequeno Príncipe, Curitiba, Brazil.
Bernadete E GomesInstituto Nacional do Cancer, Rio de Janeiro, Brazil.
Danielle M V AvelarOncobio, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0003-3130-2610
Ana Cláudia C V SoaresDiagnósticos da América, São Paulo, Brazil.ORCID 0000-0001-5676-1907
Priscila M RamosSanta Casa de Porto Alegre, Rio Grande do Sul, Brazil.
Berta SantosDiagnósticos da América, Rio de Janeiro, RJ, Brazil.
Maria L CortezNúcleo de Hematologia, Belo Horizonte, Minas Gerais, Brazil.
Miriam P BeltrameHospital Infantil Erasto Gaertner, Curitiba, Brazil.ORCID 0000-0003-0148-998X
Nydia S BacalHospital Israelita Albert Einstein, São Paulo, Brazil.
Andressa WagnerHemocentro de Florianópolis, Santa Catarina, Brazil.
Norma Lucena-SilvaInstituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.
Alex F SandesGrupo Fleury Medicina Diagnóstica, São Paulo, Brazil.
Fernanda CunhaLaboratório Sollutio, Campinas, Brazil.
Gustavo H M OliveiraLaboratório Getúlio Sales, Natal, Brazil.ORCID 0000-0001-6127-7327
Elaine S CostaInstituto de Pediatria e Puericultura Martagão Gesteira, UFRJ, Rio de Janeiro, Brazil.
Mihoko YamamotoUniversidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Hospital Amaral Carvalho · BRDASA (Brazil)Hospital Erasto Gaertner · BRSabin Medicina Diagnostica (Brazil) · BRCentro Universitário de Belo Horizonte · BRFleury S.A. (Brazil) · BRFundação Centro de Hematologia e Hemoterapia de Minas Gerais · BRHospital de Clínicas de Porto Alegre · BRHospital Israelita Albert Einstein · BRHospital Nossa Senhora das Graças · BRHospital Santa Luzia · BRInstituto de Medicina Integral Professor Fernando Figueira · BRInstituto Nacional de Câncer - INCA · BRSanta Casa Hospital · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

AMGEN BIOTECNOLOGIA DO BRASIL LTDA 7100394155
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaFlow CytometryHumansNeoplasm, ResidualB-ALLB cell acute lymphoblastic leukaemiaflow cytometryminimal residual diseaseMRDnext generation flow

Identifiers

PMID36222259
PMCPMC10091773
OpenAlexW4304689324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.